Home|Journals|Articles by Year|Audio Abstracts

Original Research

Neuropathic pain and activity disorders in breast cancer patients receiving chemotherapy

Fathul Yazid Izza, Endang Kustiowati, Widiastuti M.I, Dodik Tugasworo, Dani Rahmawati, Trianggoro Budisulistyo.

Cited by 0 Articles

Introduction: Pain is one of the complaints from breast cancer patients who received chemotherapy. One of the side effects of chemotherapy on breast cancer patients is neuronal damage resulting in neuropathic pain. The increased incidence of neuropathic pain in chemotherapy patients often results in impaired activity. This study was conducted to determine the correlation between neuropathic pain and impaired daily activity before the first injection and after the third injection in breast cancer patients receiving chemotherapy.
Methods: This was an observational analytic study with a prospective cohort design. The subjects were postoperative breast cancer patients who received chemotherapy at the Kasuari Ward, Dr Kariadi Hospital, Semarang, who fulfilled the inclusion and exclusion criteria. It was conducted from September 2019 to February 2020. Examination of neuropathic pain and pain scoring was assessed using the LANSS questionnaire and Brief Pain Inventory (BPI). Data were analyzed using Spearman's bivariate correlation test. The results were significant if the p-value

Key words: Breast cancer, neuropathic pain, chemotherapy, activity disorders

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.